A review of the medical records of thousands of adolescents treated for obesity found that kids who received the GLP-1 ...

Providing coverage for weight-loss drugs such as Wegovy and Ozempic is forcing employers to make some critical decisions.

Fat Joe opens up about his impressive 200-pound weight loss, revealing whether Ozempic played a role in his transformative ...

The company has committed £279 million ($364 million) to support national efforts aimed at reducing obesity, a critical ...

With millions of Americans taking GLP-1 medications for weight loss, the thought of taking one of these medications might ...

Chinese insulin maker Gan & Lee Pharmaceuticals is wading into the obesity world with an injectable GLP-1 agonist that beat Novo Nordisk's Ozempic (semaglutide) at lowering glycated hemoglobin (HbA1c) ...

Hoping your company will begin paying for anti-obesity medications like Wegovy? You may be in luck. A growing number of ...

GLP-1 agonists work by triggering the pancreas to produce more insulin, which reduces blood sugar levels in those with type 2 ...

Half of people who develop blood poisoning, otherwise known as sepsis, are dead within a couple of years, a new study finds.

India’s powerful copycat pharmaceutical industry is set to roll out generic weight loss drugs in the U.K. within weeks ...

Today's health news includes how the U.S. primary care crisis is hurting the fight against heart disease, the Nobel gender ...